Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoid X receptor gamma (RXRγ), also known as NR2B3, is a member of the nuclear receptor superfamily that functions as a ligand-dependent transcription factor. It forms heterodimers with other nuclear receptors such as retinoic acid receptors (RARs), thyroid hormone receptors, vitamin D receptors, and peroxisome proliferator-activated receptors (PPARs). RXRγ is primarily expressed in the brain and muscle, and plays critical roles in energy metabolism, anti-inflammation, skin health, immune function, and vision maintenance. Genetic variants have been associated with metabolic disorders and potentially cancer progression. It is activated by 9-cis-retinoic acid.
Ligand-dependent transcription factor, forms heterodimers with other nuclear receptors to enhance DNA binding and transcriptional activity on respective response elements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoid X Receptor Gamma (RXRγ).